Reuters logo
BRIEF-Master Pharm Q4 prelim net profit 2.41 mln zlotys
March 1, 2017 / 7:19 AM / 7 months ago

BRIEF-Master Pharm Q4 prelim net profit 2.41 mln zlotys

March 1(Reuters) - Master Pharm SA:

* Reported on Tuesday Q4 preliminary revenue ​of 17.11 million zlotys ($4.20 million) versus 17.96 million zlotys a year ago

* Q4 preliminary net profit was 2.41 million zlotys versus 2.92 million zlotys a year ago

Source text for Eikon:

Further company coverage: ($1 = 4.0762 zlotys)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below